Welcome to our dedicated page for Shl Telemedicine SEC filings (Ticker: SHMLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SHL Telemedicine Ltd. (SHMLF) files with the U.S. Securities and Exchange Commission as a foreign private issuer under the Securities Exchange Act of 1934. The company indicates that it uses Form 20-F for its annual reports and Form 6-K to furnish current information, such as press releases and shareholder communications.
The Form 6-K filings highlighted in the available data focus on capital structure and shareholder actions. They include press releases titled “SHL Telemedicine launches rights offering,” “SHL Telemedicine successfully completes rights offering and capital increase,” and “SHL’s shareholders confirm increase of share capital.” Another 6-K furnishes a press release titled “SHL announces Invitation to a Special General Meeting,” reflecting governance and meeting-related disclosures.
On this SEC filings page for SHMLF, users can access these 6-K reports as they are made available from the SEC’s EDGAR system. Each filing typically contains an explanatory note and an exhibit table, with the press release attached as Exhibit 99.1. Reviewing these documents can help investors understand how SHL Telemedicine Ltd. raises capital through rights offerings, how share capital increases are approved, and how special general meetings are convened.
Alongside direct access to the filings, AI-powered tools on this page can summarize the key points in lengthy documents, highlight the main terms of rights offerings or capital increases, and clarify the nature of shareholder approvals described in the exhibits. This can make it easier to interpret SHL Telemedicine Ltd.’s Form 6-K and Form 20-F disclosures without reading every page in detail.
SHL Telemedicine Ltd. filed a Form 6-K to inform investors that it has successfully completed a rights offering and related capital increase. The company reports that this was announced in a press release dated December 3, 2025, titled “SHL Telemedicine successfully completes rights offering and capital increase,” which is attached to the report as an exhibit. The filing is signed by the Chief Financial Officer, Lior Haalman, on behalf of the company.
SHL Telemedicine Ltd. filed a Form 6-K reporting that it has issued a press release titled “SHL Telemedicine launches rights offering.” The company is a foreign private issuer based in Tel Aviv, Israel, and the press release is attached as an exhibit and incorporated by reference into this report. The filing itself mainly serves to formally notify investors that details of the planned rights offering are provided in the accompanying press release.
SHL Telemedicine Ltd. (SHMLF) submitted a Form 6-K as a foreign private issuer to provide an update to investors. The company reports that on November 20, 2025 it issued a press release titled “SHL’s shareholders confirm increase of share capital.”
The filing states that this press release is attached as Exhibit 99.1 and incorporated by reference, indicating that SHL’s shareholders have formally confirmed an increase in the company’s share capital. The Form 6-K itself is largely administrative, serving to furnish this press release to the market under U.S. securities law.
SHL Telemedicine Ltd. submitted a report noting that it has issued a press release titled “SHL announces Invitation to a Special General Meeting.”
The company states that this press release, inviting shareholders to a Special General Meeting, is provided as an exhibit and incorporated by reference into the report.